Rubenstein, L M <br/><br/>
Economic and health-related quality of life considerations of new therapies in Parkinson's disease.  [electronic resource] 

 -  PharmacoEconomics  2001 
 - 729-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1170-7690 
<br/><br/><label>Standard No.: </label>10.2165/00019053-200119070-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cost of Illness<br/>Cost-Benefit Analysis<br/>Health Care Costs<br/>Health Status<br/>Humans<br/>Parkinson Disease--drug therapy<br/>Quality of Life